We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

20 hedge funds and large institutions have $9M invested in Alimera Sciences in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

11% more funds holding

Funds holding: 18 → 20 (+2)

6% more capital invested

Capital invested by funds: $8.49M → $9M (+$512K)

Holders
20
Holders Change
+2
Holders Change %
+11.11%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VCIM
Velan Capital Investment Management
Georgia
+$1.03M
2
Citadel Advisors
Citadel Advisors
Florida
+$79.2K
3
PCM
Perritt Capital Management
Illinois
+$40.7K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$20.5K
5
Renaissance Technologies
Renaissance Technologies
New York
+$16K

Top Sellers

Rank Fund Capital Flow
1
CCPM
Cooper Creek Partners Management
New York
-$438K
2
OIA
Optimum Investment Advisors
Illinois
-$22K
3
BlackRock
BlackRock
New York
-$18.3K
4
Citigroup
Citigroup
New York
-$10.7K
5
JP Morgan Chase
JP Morgan Chase
New York
-$5.92K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$3.08M – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.37M – – –
PAI
3
Palo Alto Investors
California
$1.1M – – –
VCIM
4
Velan Capital Investment Management
Georgia
$1.02M +$1.03M +187,001 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$817K +$20.5K +3,726 +3%
Renaissance Technologies
6
Renaissance Technologies
New York
$698K +$16K +2,900 +2%
Deutsche Bank
7
Deutsche Bank
Germany
$153K – – –
PCM
8
Perritt Capital Management
Illinois
$150K +$40.7K +7,400 +37%
BlackRock
9
BlackRock
New York
$143K -$18.3K -3,326 -11%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$143K +$6.75K +1,227 +5%
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$107K – – –
BCM
12
Bridgeway Capital Management
Texas
$100K – – –
Citadel Advisors
13
Citadel Advisors
Florida
$79K +$79.2K +14,402 New
OIA
14
Optimum Investment Advisors
Illinois
$22K -$22K -4,000 -49%
JP Morgan Chase
15
JP Morgan Chase
New York
$12K -$5.92K -1,076 -33%
TRCT
16
Tower Research Capital (TRC)
New York
$6K +$6.36K +1,156 New
AA
17
Ancora Advisors
Ohio
$2K – – –
CCPM
18
Cooper Creek Partners Management
New York
– -$438K -78,170 Closed
Citigroup
19
Citigroup
New York
– -$10.7K -1,952 -100%
Wells Fargo
20
Wells Fargo
California
– +$17 +3 +11%

ALIM Hedge Fund Activity: Q2 2022 in Review

20 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2022, worth a combined $9M — up 6% from $8.49M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ALIM positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was Velan Capital Investment Management, opening a new position worth an estimated $1.03M. The largest seller was Cooper Creek Partners Management, exiting entirely with an estimated $438K sold.

  • 20 institutional investors held Alimera Sciences (ALIM) as of Q2 2022, up from 18 in Q1 2022.
  • Funds reported $9M of Alimera Sciences stock for Q2 2022, up 6% quarter-over-quarter.
  • 3 funds opened new Alimera Sciences positions in Q2 2022 and 1 closed out, a net change of +2 holders.
  • The largest Alimera Sciences buyer in Q2 2022 was Velan Capital Investment Management, an estimated $1.03M added.
  • The largest Alimera Sciences seller in Q2 2022 was Cooper Creek Partners Management, an estimated $438K sold.

Based on aggregated 13F filings for Q2 2022.